I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 47% ± 16% | |
| glutamatergic neuron | 4 studies | 32% ± 14% | |
| interneuron | 3 studies | 47% ± 7% | |
| neuron | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 5 studies | 47% ± 16% | |
| glutamatergic neuron | 4 studies | 32% ± 14% | |
| interneuron | 3 studies | 47% ± 7% | |
| neuron | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1174.07 | 328 / 328 | 90% | 11.70 | 161 / 178 |
| thymus | 95% | 322.99 | 620 / 653 | 72% | 7.42 | 433 / 605 |
| esophagus | 79% | 370.54 | 1142 / 1445 | 70% | 12.34 | 129 / 183 |
| bladder | 81% | 1093.00 | 17 / 21 | 64% | 18.38 | 324 / 504 |
| prostate | 90% | 287.98 | 221 / 245 | 48% | 2.90 | 241 / 502 |
| lung | 58% | 144.54 | 333 / 578 | 80% | 15.74 | 928 / 1155 |
| breast | 88% | 311.14 | 402 / 459 | 50% | 5.76 | 559 / 1118 |
| brain | 90% | 1130.13 | 2385 / 2642 | 29% | 2.44 | 202 / 705 |
| uterus | 47% | 110.74 | 80 / 170 | 69% | 12.19 | 316 / 459 |
| ureter | 0% | 0 | 0 / 0 | 100% | 139.39 | 1 / 1 |
| intestine | 84% | 352.52 | 808 / 966 | 13% | 1.51 | 71 / 527 |
| spleen | 89% | 263.02 | 214 / 241 | 0% | 0 | 0 / 0 |
| ovary | 48% | 83.41 | 87 / 180 | 36% | 3.13 | 153 / 430 |
| adipose | 82% | 292.22 | 989 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 11.53 | 36 / 45 |
| skin | 71% | 246.47 | 1278 / 1809 | 5% | 1.19 | 22 / 472 |
| stomach | 48% | 115.14 | 171 / 359 | 18% | 1.79 | 52 / 286 |
| blood vessel | 42% | 118.96 | 555 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 9.51 | 12 / 258 | 22% | 3.04 | 50 / 230 |
| kidney | 20% | 67.80 | 18 / 89 | 2% | 0.27 | 20 / 901 |
| muscle | 18% | 24.75 | 147 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 7% | 0.74 | 28 / 406 |
| heart | 7% | 7.88 | 56 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
| peripheral blood | 0% | 0.25 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009134 | Biological process | nucleoside diphosphate catabolic process |
| GO_0009143 | Biological process | nucleoside triphosphate catabolic process |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004382 | Molecular function | GDP phosphatase activity |
| GO_0045134 | Molecular function | UDP phosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0017110 | Molecular function | nucleoside diphosphate phosphatase activity |
| GO_0004050 | Molecular function | apyrase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0017111 | Molecular function | ribonucleoside triphosphate phosphatase activity |
| Gene name | ENTPD3 |
| Protein name | Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6) Ectonucleoside triphosphate diphosphohydrolase 3 |
| Synonyms | CD39L3 |
| Description | FUNCTION: Has a threefold preference for the hydrolysis of ATP over ADP. . |
| Accessions | ENST00000301825.8 [O75355-1] ENST00000647765.1 O75355 C9J0J3 ENST00000445129.1 [O75355-2] A0A3B3IT06 ENST00000439533.5 ENST00000456402.5 [O75355-1] |
